Merus N.V. (MRUS) Prices 3.86M Share Offering at $28.50/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Merus N.V. (MRUS) Announces Proposed Stock Offering, Size not Disclosed
November 4, 2021 4:09 PM EDTMerus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the launch of a proposed underwritten public offering of its common shares (the Offer Shares). All of the common shares are being offered by Merus. In addition, Merus expects to grant the underwriters a 30-day option to purchase an additional 15% of the Offer Shares (the Option Shares and together with the Offer Shares, the Shares). The offering is subject to market conditions and other closing conditions, and there can be no assurance as to whether or... More
Merus N.V. (MRUS) PT Raised to $33 at RBC Capital
November 3, 2021 6:12 AM EDTRBC Capital analyst Brian Abrahams raised the price target on Merus N.V. (NASDAQ: MRUS) to $33.00 (from $21.00) while maintaining a Sector Perform rating.... More
